Iowa Clinical Trials

Recruiting studies in Iowa

• The ED-AWARENESS-2 Trial
  NCT05534243NAWashington University School of MedicineAwarenessIowa City, IA
• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
  NCT04561518Alnylam PharmaceuticalsTransthyretin-Mediated AmyloidosisIowa City, IA
• Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
  NCT04924075PHASE2Merck Sharp & Dohme LLCPheochromocytoma/ParagangliomaIowa City, IA
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerCedar Rapids, IA
• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
  NCT07310420PHASE1TerSera Therapeutics LLCAdvanced Breast CancerDes Moines, IA
• MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
  NCT05655312PHASE1, PHASE2Perspective TherapeuticsRecurrent Melanoma (Skin)Iowa City, IA
• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801PHASE3Merck Sharp & Dohme LLCCrohn's DiseaseClive, IA
• A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
  NCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisDes Moines, IA
• The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
  NCT07143019NAphenox Inc.Hemorrhagic StrokeIowa City, IA
• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
  NCT07630974PHASE1, PHASE2Merck Sharp & Dohme LLCMalignant NeoplasmIowa City, IA
• MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
  NCT05564390PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaAnkeny, IA
• Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
  NCT06641414PHASE3Ascentage Pharma Group Inc.Higher-risk Myelodysplastic SyndromeIowa City, IA

See all 726 recruiting trials →

Popular conditions in Iowa

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Iowa?

Corterve aggregates actively recruiting clinical trials with sites in Iowa from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Iowa free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Iowa?

Iowa research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.